CHI3L1 and non-small cell lung carcinoma: ELISA results showed that increased plasma CHI3L1 concentration correlated with poorer overall survival and disease-free survival of our in-house cohort of NSCLC (n = 161), PDAC (n = 155) and CRC (n = 180) patients (Figure 10A-F and Table S3).